# Efficacy of Indacaterol 150 µg Versus Formoterol

> **NCT01377428** · PHASE4 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Indacaterol
- **DRUG:** Formoterol

## Key facts

- **NCT ID:** NCT01377428
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377428, "Efficacy of Indacaterol 150 µg Versus Formoterol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01377428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*